2,3-dinor, 6-keto-PGF1alpha

2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha

MeSH term MeSH ID Detail
Inflammation D007249 119 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Body Weight D001835 333 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Tibial Fractures D013978 4 associated lipids
Thrombosis D013927 49 associated lipids
Endometriosis D004715 29 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Cerebral Hemorrhage D002543 13 associated lipids
Per page 10 20 50 | Total 25

NCBI Entrez Crosslinks

All references with 2,3-dinor, 6-keto-PGF1alpha

Download all related citations
Per page 10 20 50 100 | Total 191
Authors Title Published Journal PubMed Link
Edlund A et al. Leg exercise increases prostacyclin synthesis without activating platelets in both healthy and atherosclerotic humans. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2959097
Ciabattoni G et al. Radioimmunoassay measurement of 2,3-dinor metabolites of prostacyclin and thromboxane in human urine. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960163
Reilly IA et al. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. 1986 Circulation pmid:2938849
Reilly IA et al. Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. 1986 Br Med J (Clin Res Ed) pmid:3083991
Fischer S et al. Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites. 1986 Biochim. Biophys. Acta pmid:3754157
Reilly IA and FitzGerald GA Eicosenoid biosynthesis and platelet function with advancing age. 1986 Thromb. Res. pmid:3754355
Guarner F et al. Increased synthesis of systemic prostacyclin in cirrhotic patients. 1986 Gastroenterology pmid:3510938
Vesterqvist O Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS. 1986 Eur. J. Clin. Pharmacol. pmid:3519239
Kuehl PG et al. Systemic production of prostacyclin and thromboxane A2 does not correlate with patency of the ductus arteriosus in very low birth weight infants. 1986 J. Pediatr. pmid:3519915
Knapp HR et al. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. 1986 N. Engl. J. Med. pmid:3007982